PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of <i>BRAF</i> V600E Mutational Status
Allison Martin(Albert Einstein College of Medicine), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Elizabeth L. Engle(Bloomberg (United States)), Laura Asnaghi(Johns Hopkins Medicine), Ming Yuan(Heilongjiang Provincial Academy of Agricultural Sciences), Lauren Harris(Brigham and Women's Hospital), Bradley Poore(University of Pittsburgh), Eric H. Raabe(Johns Hopkins University), Michael Lim(Johns Hopkins Hospital), William R. Bell(University of Minnesota Medical Center), Antje Arnold(Johns Hopkins University)
Cited by 16
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k